BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Tauopathies Treatment Market: Rise in incidence of neurodegenerative diseases to drive the market

  As per the NCBI (National Center for Biotechnology Information), tauopathies are described as neurodegenerative disorders caused by abnormal deposition of tau protein in the brain.

  February 15, 2022

   · 

  5 min read
• BioMidwest

  Oligon to Present at Biocom Global Life Science Partnering Conference

  Oligon™ Inc. announced that Dr. Spyro Mousses, Chief Executive Officer of Oligon, will be presenting at the 12th Annual Biocom Global Life Science Partnering Conference.

  February 15, 2022

   · 

  1 min read
• Business

  Veracyte to Release Fourth Quarter and Full-Year 2021 Financial Results on February 28, 2022

  Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release its full financial results for the fourth quarter and full-year 2021 after the close of market on Monday, February 28, 2022.

  February 15, 2022

   · 

  1 min read
• Business

  Champions Oncology Announces a Partnership with GigaMune to Discover Novel Tumor-Reactive T Cell Receptors

  Champions Oncology, Inc. announced today a co-development partnership with GigaMune.

  February 15, 2022

   · 

  3 min read
• Business

  Jaguar Health Announces Receipt by Napo Therapeutics of Small and Medium Enterprise (SME) Designation from the European Medicines Agency

  Jaguar Health today announced that Napo Therapeutics has been granted Small and Medium Enterprise (SME) designation by the European Medicines Agency (EMA).

  February 15, 2022

   · 

  3 min read
• BioMidwest

  XIL Health Develops Interactive Vaccine Dashboard with COVID Tracker for Pharmacies Nationwide

  XIL Health, today announces its innovative Vaccine Dashboard for U.S.-based retail pharmacies - allowing easy access to tracked information on COVID-19 and all other vaccines given by pharmacies, including pediatric vaccines.

  February 15, 2022

   · 

  3 min read
• Business

  Novan to Report Full Year 2021 Financial Results on February 22, 2022

  Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its full year 2021 financial results on Tuesday, February 22nd.

  February 15, 2022

   · 

  1 min read
• Biotech Beach

  AXIM Biotech Announces New Milestones in Preparation of Dry Eye Disease Diagnostics Launch

  AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting dry eye disease (DED), today announced two key milestones in preparation of the launch of its DED diagnostics testing initiative.

  February 15, 2022

   · 

  7 min read
• FDA

  Neurocentria Obtains FDA Approval to Conduct Pivotal Phase IIb/III Clinical Trial for Testing Safety and Efficacy of Drug Candidate NRCT-101SR in Adults With ADHD

  Neurocentria Inc., has received FDA approval to conduct a pivotal phase IIb/III human clinical trial to test the efficacy and safety of its leading drug candidate NRCT-101SR compared to inactive placebo in adults with ADHD.

  February 15, 2022

   · 

  5 min read
• Drug Development

  Statera Biopharma, Inc., Announces Central Institutional Review Board Approval of Phase 3 Clinical Trial for Pediatric Crohn’s Disease

  Statera Biopharma, Inc. (Nasdaq: STAB), announced today that it has received Central Institutional Review Board (IRB) approval to conduct a Phase 3 clinical trial for STAT-201 in the treatment of pediatric Crohn’s Disease (CD), a chronic relapsing inflammatory condition of the gastrointestinal tract.

  February 15, 2022

   · 

  4 min read